Mifepristone Returns to the Shadow Docket

Source: Reason.com · Bias: Center Right

Summary

Drug makers seek interim relief after the U.S. Court of Appeals for the Fifth Circuit blocks FDA rule allowing mifepristone prescriptions via telemedicine.

Related Coverage

Daily Analysis

Read the full Parallax Pulse for May 4, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.

More Headlines From May 4, 2026

Reason.com

Mifepristone Returns to the Shadow Docket

Center Right

Drug makers seek interim relief after the U.S. Court of Appeals for the Fifth Circuit blocks FDA rule allowing mifepristone prescriptions via telemedicine.

Mifepristone Returns to the Shadow Docket | Compare Perspectives | ParallaxNews.io